Associations Between Antibiotic Use and Outcomes in Patients Hospitalized With Community-Acquired Pneumonia and
Brett Biebelberg1, Tom Chen2, Cara McKenna2
1Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Background:
Newly released community-acquired pneumonia (CAP) guidelines include a conditional recommendation to treat all hospitalized patients with positive respiratory virus assays with antibacterials. We assessed the frequency, duration, and outcomes of antibacterial prescribing in this population.
Methods:
We retrospectively identified all hospitalized patients with possible CAP and a positive respiratory virus test at 5 hospitals, June 2015-December 2024. We used detailed clinical data to propensity-weight patients treated with 0-2 versus 5-7 days of antibacterials and compared outcomes overall and for different viruses.
Results:
Among 6779 patients with possible CAP and a respiratory virus, 3269 were treated with 0-2 days and 1560 with 5-7 days of antibacterials. After propensity-weighting 2614 patients (1720 treated 0-2 days, 894 treated 5-7 days), there were no significant differences in hospital length of stay (11.7 days vs 11.1 days; OR 1.05, 95% CI .97-1.15), ICU admission after 48 hours (28.3% vs 28.2%; OR 1.01, 95% CI .86-1.18), in-hospital mortality (9.5% vs 9.8%; OR 0.97, 95% CI .74-1.27), or 30-day hospital-free days (16.9 days vs 17.0 days; OR 0.99, 95% CI .95-1.03). Results were consistent when restricted to non-SARS-CoV-2 viruses and to influenza alone, when comparing 0 versus 5-7 days of antibacterials, and when restricting to patients with ICD-10 codes for pneumonia present on admission.
Conclusions:
Antibacterial use for patients with possible CAP and respiratory viruses is highly variable but outcomes are similar with 0-2 versus 5-7 days of antibacterials. This suggests antibiotics are not beneficial in most CAP patients who test positive for respiratory viruses.
More Related Videos
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
09:26Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Published on: January 22, 2021
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
01:29Pneumonia II: Pathophysiology